Pharma Journalist - Page 70 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

AbbVie, ADARx Partner on Next-Gen siRNA Therapies

Recipharm and PLG Form Partnership to Accelerate Drug Development

Injectable Drug Delivery 2025 – Driving Innovation Through Collaboration

Perjeta Regimen Cuts Death Risk by 17% in HER2+ Breast Cancer

Trixeo Aerosphere Approved in UK as First Inhaled Respiratory Drug with Near-Zero GWP Propellant

Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP

Beam Therapeutics’ BEAM-302 Granted RMAT Designation by FDA for AATD Treatment

Novo Nordisk’s Once-Weekly Sogroya Proves Effective in Children with Growth Disorders

Amneal and ApiJect Partner to Boost U.S. Sterile BFS Manufacturing Capacity

HAYA Therapeutics Secures $65M Series A to Advance RNA-Guided Therapies for Chronic Diseases